NSRA HomepageNSRA Web editorialNSRA EventsNSRA Merchandise

NSRA forum - Diflucan -35%OFF - Free Shipping - Diflucan Online
NSRA forum
Username:
Password:
Save Password


Register
  Home   Forums     FAQ  
Active Topics | Active Polls | Resources | Members | Online Users | Live Chat | Avatar Legend | Search | Statistics
[ Active Members: 0 | Anonymous Members: 0 | Guests: 4 ]  [ Total: 4 ]  [ Newest Member: 49anglia ]
 All Forums
 NSRA Forums
 NSRA hotrod / streetrod discussion
 Diflucan -35%OFF - Free Shipping - Diflucan Online
 Forum Locked |   Topic Locked |   Printer Friendly
Author Previous Topic: SECURITY AT THE NATS Topic Next Topic: CALLING STEVE LANG  

Skimmer
NSRA Member

Posted - 15 Aug 2003 :  9:59:50 PM  Show Profile
Diflucan -35%OFF - Free Shipping - Diflucan Online Best in Internet Diflucan Online Diflucan, or similar drugs such as clotrimazole (Lotrimin), econazole (Spectazole), ketoconazole DIFLUCAN (fluconazole), the first of a new subclass of synthetic triazole antifungal agents DIFLUCAN tablets contain 50, 100, 150, or 200 mg of fluconazole and the following inactive ingredients: microcrystalline cellulose, dibasic calcium phosphate Diflucan is used to treat fungal infections called candidiasis (also known as thrush or yeast infections) It is commonly marketed under the trade name Diflucan (Pfizer). Definition of Program Offer Pfizer Inc makes available free of charge its antifungal medicine The Diflucan Partnership Program also includes the training of health professionals in the diagnosis and treatment of opportunistic infections. Diflucan is an antifungal antibiotic. Diflucan may also be used for purposes other than those listed in this medication guide DIFLUCAN for oral suspension contains 350 mg or 1400 mg of fluconazole DIFLUCAN injection is an iso-osmotic, sterile, nonpyrogenic solution Hepatic injury: DIFLUCAN has been associated with rare cases of serious hepatic toxicity, including fatalities primarily in patients with serious underlying medical conditions. In cases of DIFLUCAN-associated DIFLUCAN hepatotoxicity has usually, but not always, been reversible on discontinuation of therapy. Patients who develop abnormal liver function tests during DIFLUCAN therapy should be monitored for the development of more severe hepatic injury. DIFLUCAN should be discontinued if clinical signs and symptoms consistent with liver disease develop that may be attributable to DIFLUCAN.

Country: United Kingdom | Posts: 25576
  Previous Topic: SECURITY AT THE NATS Topic Next Topic: CALLING STEVE LANG  
 Forum Locked |   Topic Locked |   Printer Friendly
Jump To:
NSRA forum © NSRA 2006 Go To Top Of Page
This page took 0.38 seconds to load Powered By: Snitz Forums 2000